Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.86% | -23.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.86% | -23.49% | |||
| Cost of Revenue | -9.76% | -19.30% | |||
| Gross Profit | -9.88% | -24.49% | |||
| SG&A Expenses | -5.17% | 2.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.56% | -1.03% | |||
| Operating Income | -8.93% | -10,219.21% | |||
| Income Before Tax | -9.27% | -3,078.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.27% | -3,078.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.27% | -3,078.04% | |||
| EBIT | -8.93% | -10,219.21% | |||
| EBITDA | -9.73% | -1,308.20% | |||
| EPS Basic | -8.66% | -3,076.25% | |||
| Normalized Basic EPS | -8.69% | -3,428.89% | |||
| EPS Diluted | -8.66% | -2,297.17% | |||
| Normalized Diluted EPS | -8.69% | -3,428.89% | |||
| Average Basic Shares Outstanding | 0.55% | 0.51% | |||
| Average Diluted Shares Outstanding | 0.55% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||